The expression of CXCL8 and CCND1 was significantly diminished in all melanoma cell lines, irrespective of their basal mRNA and protein levels that confirmed the inhibitory effect of 17-aminogeldanamycin on NF-κB activity. This evidence concerns the gene NFKB1 and melanoma.